SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-005510
Filing Date
2021-01-26
Accepted
2021-01-26 19:02:05
Documents
1
Period of Report
2020-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3964
  Complete submission text file 0001209191-21-005510.txt   5378
Mailing Address C/O ASPREVA PHARMACEUTICALS CORPORATION 1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8
Business Address
Glickman Richard M (Reporting) CIK: 0001352637 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37410 | Film No.: 21556105

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations